跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-BOSENTAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-BOSENTAN
Authorized
STANDARD
TARO-BOSENTAN
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1d243ab507dfa1fe
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
1d243ab507dfa1fe
Drug Approval Canada Name
TARO-BOSENTAN
Product Name
TARO-BOSENTAN
Status
Marketed
Status Date
2020-05-07
Original Market Date
2020-05-07
Din
02483149
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
48:48.12
Atc Original
C02KX01 BOSENTAN
Atc Name
c 02 kx 01
Aig Number
0145922002
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive, Brampton, Ontario, Canada, L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Active Ingredients
BOSENTAN (BOSENTAN MONOHYDRATE)
125 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1d243ab507dfa1fe
Type
Standard
Back to Health Canada Approvals